1-(2,3-dihydro-1-benzofuran-5-yl)propan-1-one

Compound number
MolPort-001-004-319
CAS number
68660-11-7
IUPAC
1-(2,3-dihydro-1-benzofuran-5-yl)propan-1-one
IUPAC traditional
1-(2,3-dihydro-1-benzofuran-5-yl)propan-1-one
SMILES
CCC(=O)c1ccc2OCCc2c1
InChI key
QYYIGDKFUBVDDO-UHFFFAOYSA-N
Molecular formula
Molecular weight
176.215
Solubility
not available

Marketplace Offers

BLD Pharmatech (made-to-order)

Direct S&H to USA 90.00 USD Direct S&H to World: 95.00 USD
Catalog
Building blocks
Ships out
25 business days
Purity
95%
Last updated
this week
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 g August 11, 2022 443.00 USD
Add to Cart Buy

MedChemExpress (made-to-order)

Direct S&H to USA 50.00 USD Direct S&H to World: 85.00 USD
Catalog
Building blocks
Ships out
20 business days
Purity
>98%
Last updated
this month
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
25 mg August 4, 2022 129.00 USD
Add to Cart Buy
50 mg August 4, 2022 132.87 USD
Add to Cart Buy
100 mg August 4, 2022 197.37 USD
Add to Cart Buy

Get your compounds in the right format

MolPort Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-001-004-319
CAS number
68660-11-7

Names, Synonyms and 3rd Party Identifiers

Name
1-(2,3-Dihydrobenzofuran-5-yl)propan-1-one
1-(2,3-dihydro-1-benzofuran-5-yl)propan-1-one
MFCD00508394

InChI

InChI
1/C11H12O2/c1-2-10(12)8-3-4-11-9(7-8)5-6-13-11/h3-4,7H,2,5-6H2,1H3
InChI key
QYYIGDKFUBVDDO-UHFFFAOYSA-N

Formula

Molecular formula
C11H12O2
Molecular weight
176.215

MolPort Guarantee

When you purchase products through the MolPort website from any seller other than MolPort itself, you will be protected by the MolPort Guarantee. If you purchase products from MolPort itself, this MolPort Guarantee will not apply, and your remedies will be governed by the MolPort Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more

Feedback